| Identifier |
19980325_nanos_sciplatform3_01 |
| Title |
Primary Immunosuppresive Treatment of Ocular Myasthenia Gravis with Cyclosporine A |
| Creator |
Preston C. Calvert |
| Affiliation |
Fairfax, VA |
| Subject |
Immunosuppressive Treatment; Ocular Myasthenia Gravis; Cyclosporine A |
| Description |
Immunosuppressive therapy for ocular myasthenia gravis (MG) has usually consisted of systemic corticosteroids or azathioprine. Although each drug can induce a remission, each has drawbacks. Cyclosporine A (CsA) has been demonstrated in a controlled trial to be effective and safe in the suppression of MG. I report here my experience with 8 patients with ocular MG treated with CsA as the primary immunosuppressive modality. |
| Date |
1998-03-25 |
| Language |
eng |
| Format |
application/pdf |
| Type |
Text |
| Source |
1998 North American Neuro-Ophthalmology Society Annual Meeting |
| Relation is Part of |
NANOS 1998: Platform Presentations (Session III) |
| Collection |
Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/ |
| Publisher |
North American Neuro-Ophthalmology Society |
| Holding Institution |
Spencer S. Eccles Health Sciences Library, University of Utah |
| Rights Management |
Copyright 1998. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
| ARK |
ark:/87278/s6cg2wvg |
| Setname |
ehsl_novel_nam |
| ID |
184376 |
| Reference URL |
https://collections.lib.utah.edu/ark:/87278/s6cg2wvg |
